Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Opfolda 65 mg hard capsules

Active Ingredient:
miglustat
Company:  
Amicus Therapeutics UK Ltd See contact details
ATC code: 
A16AX06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Cipaglucosidase Alfa Home Infusion Patient Diary

Supplementary Home Infusion Patient Diary

{pdf_link}

Cipaglucosidase Alfa Home Infusion Patient Manual

Home Infusion Patient Manual

{pdf_link}

Patient Reminder Card for Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for women of childbearing potential

Patient reminder card

{pdf_link}

Pombiliti (Cipaglucosidase Alfa) + Opfolda (Miglustat) Information Pack For Healthcare Professionals

Information Pack For Healthcare Professionals

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Amicus Therapeutics UK Ltd
Company image
Address
One Globeside, Fieldhouse Lane, Marlow, SL7 1HZ
Telephone
+44 01753 888 567
Medical Information Direct Line
08082346864
Medical Information e-mail
[email protected]
WWW
http://www.amicusrx.co.uk